Altimmune, Inc.
ALT· Nasdaq
Altimmune, Inc.
- Last sale
- Oct 2, 2026 · -0.55%
- Market cap
- $532.01M
- 194.52M shares
- Filings
- 1,010
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $41,000 | reported | |
| FY 2024 | 2024-12-31 | $20,000 | reported | |
| FY 2023 | 2023-12-31 | $426,000 | reported | |
| FY 2022 | 2022-12-31 | $68,000 | reported | |
| FY 2021 | 2021-12-31 | $4,410,356 | reported | |
| FY 2020 | 2020-12-31 | $8,185,027 | reported | |
| FY 2019 | 2019-12-31 | $5,801,401 | reported | |
| FY 2018 | 2018-12-31 | $10,331,168 | reported | |
| FY 2017 | 2017-12-31 | $10,738,322 | reported | |
| FY 2016 | 2016-12-31 | $3,236,175 | reported | |
| FY 2011 | 2011-12-31 | $24,266,274 | reported | |
| FY 2010 | 2010-12-31 | $20,993,605 | reported |
Altimmune, Inc. · CIK 1326190 · Engraved from SEC EDGAR
